MPLT · Categories · Coverage

MPLT - Analyst coverage initiated

MapLight Therapeutics Inc. (MPLT) analyst coverage initiated - real-time wire coverage filtered to Coverage only.

Recent Coverage for MPLT

• 25d
  Raymond James initiated coverage on MapLight Therapeutics with a new price target

  Raymond James initiated coverage of MapLight Therapeutics with a rating of Strong Buy and set a new price target of $46.00
• 54d
  UBS initiated coverage on MapLight Therapeutics with a new price target

  UBS initiated coverage of MapLight Therapeutics with a rating of Buy and set a new price target of $48.00
• 60d
  Craig Hallum initiated coverage on MapLight Therapeutics with a new price target

  Craig Hallum initiated coverage of MapLight Therapeutics with a rating of Buy and set a new price target of $43.00
• 77d
  H.C. Wainwright initiated coverage on MapLight Therapeutics with a new price target

  H.C. Wainwright initiated coverage of MapLight Therapeutics with a rating of Buy and set a new price target of $45.00
• 103d
  Needham initiated coverage on MapLight Therapeutics with a new price target

  Needham initiated coverage of MapLight Therapeutics with a rating of Buy and set a new price target of $37.00
• 104d
  TD Cowen initiated coverage on MapLight Therapeutics

  TD Cowen initiated coverage of MapLight Therapeutics with a rating of Buy
• 123d
  Canaccord Genuity initiated coverage on MapLight Therapeutics with a new price target

  Canaccord Genuity initiated coverage of MapLight Therapeutics with a rating of Buy and set a new price target of $35.00
• 241d
  Morgan Stanley initiated coverage on MapLight Therapeutics with a new price target

  Morgan Stanley initiated coverage of MapLight Therapeutics with a rating of Overweight and set a new price target of $34.00
• 241d
  Stifel initiated coverage on MapLight Therapeutics with a new price target

  Stifel initiated coverage of MapLight Therapeutics with a rating of Buy and set a new price target of $28.00
• 241d
  Jefferies initiated coverage on MapLight Therapeutics with a new price target

  Jefferies initiated coverage of MapLight Therapeutics with a rating of Buy and set a new price target of $32.00
• 241d
  Leerink Partners initiated coverage on MapLight Therapeutics with a new price target

  Leerink Partners initiated coverage of MapLight Therapeutics with a rating of Outperform and set a new price target of $30.00

Other MPLT categories

• 8-K
• 10-K
• 10-Q
• S-1
• 13D
• 13G
• Form 4
• Form 3
• Form 5
• DEF 14A
• M&A
• Earnings